Get started
Author

Marianne Ingerslev Holt

Observed names: Holt, MI, M.I. Holt
Institution: Vejle Sygehus
ORCID: 0000-0003-0637-9560
Observed ORCID: 0000-0003-0637-9560
OpenAlex ID: A5057182772
Remote Symptom Monitoring of Patients With Advanced Lung Cancer (The ProWide Study): A Randomized Controlled Trial
2024 · Rasmus Blechingberg Friis, Helle Pappot, et al. · JCO Oncology Practice · 7
989P Efficacy of molecularly matched, targeted therapies outside current drug indications: Results from the first 301 patients treated in the ProTarget trial
2025 · T.M. Kringelbach, L. Belcaid, et al. · Annals of Oncology · 1
The Enemy of My Enemy: Two Cases of De Novo Metastatic Small-Cell Neuroendocrine Prostate Cancer with BRCA2 Alterations and Brain Metastases
2026 · Mads Fallesen Kjer, Mads Hvid Poulsen, et al. · International Journal of Molecular Sciences
ProTarget – An investigator-initiated Danish Nationwide Clinical Trial on Targeted Cancer Treatment based on Genomic Profiling. Trial, Overview and Status
2024 · Kringelbach, TM, Højgaard, M, et al. · VBN Forskningsportal (Aalborg Universitet)
Prognostic Image Biomarkers in the Treatment of Patients with Locally Advanced NSCLC
2022 · M. Tvilum, C.M. Lutz, et al. · International Journal of Radiation Oncology*Biology*Physics
PO-1262 Early response to chemotherapy as predictor of locoregional and distant failure in NSCLC
2022 · M. Tvilum, M.M. Knap, et al. · Radiotherapy and Oncology
Works count: 6
Citation count: 8
H-index: 1
I10-index:
Year
Topic
Type